Addus HomeCare (NASDAQ:ADUS) EVP Brian Poff Sells 2,041 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Brian Poff sold 2,041 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $218,346.18. Following the sale, the executive vice president directly owned 64,512 shares of the company’s stock, valued at $6,901,493.76. This represents a 3.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Brian Poff also recently made the following trade(s):

• On Wednesday, February 25th, Brian Poff sold 820 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total value of $86,395.20.

Addus HomeCare Trading Down 0.7%

Shares of ADUS stock opened at $103.29 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The business has a 50-day moving average price of $109.41 and a two-hundred day moving average price of $113.01. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The firm has a market cap of $1.91 billion, a P/E ratio of 19.83, a price-to-earnings-growth ratio of 1.49 and a beta of 0.91.

Wall Street Analysts Forecast Growth

Several research firms have commented on ADUS. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Royal Bank Of Canada reiterated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Finally, BMO Capital Markets initiated coverage on Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $134.33.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently modified their holdings of the company. Global Retirement Partners LLC boosted its holdings in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC increased its holdings in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare during the 4th quarter valued at approximately $29,000. Arax Advisory Partners lifted its holdings in Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares during the period. Finally, Private Trust Co. NA lifted its holdings in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare News Summary

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.